MusclePharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
April 14, 2022 at 04:25 pm EDT
MusclePharm Corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was USD 50.04 million compared to USD 64.44 million a year ago. Net loss was USD 12.87 million compared to net income of USD 3.19 million a year ago. Basic loss per share from continuing operations was USD 0.39 compared to basic earnings per share from continuing operations of USD 0.1 a year ago. Diluted loss per share from continuing operations was USD 0.39 compared to diluted earnings per share from continuing operations of USD 0.08 a year ago.